13 Best Healthcare Dividend Stocks to Invest in

8. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Holders: 85

AbbVie Inc. (NYSE:ABBV) ranks eighth on our list of the best dividend stocks from the healthcare sector. The American multinational pharmaceutical company offers a quarterly dividend of $1.64 per share and has a dividend yield of 3.10%, as recorded on March 20. It has been rewarding shareholders with growing dividends for the past 52 consecutive years.

AbbVie Inc. (NYSE:ABBV) is dedicated to developing and bringing innovative treatments to market across multiple healthcare sectors. As a leading pharmaceutical firm, its broad portfolio includes treatments in immunology, oncology, neurology, and eye care. It also holds a strong presence in the aesthetics industry, offering well-known cosmetic products like Juvederm and Botox for skincare and anti-aging. Since the start of 2025, its stock has risen by nearly 18%.

In the fourth quarter of 2024, AbbVie Inc. (NYSE:ABBV) reported revenue of $15.1 billion, reflecting a 5.6% year-over-year increase and exceeding analysts’ expectations of $14.87 billion. On a GAAP basis, the company posted a net loss of $0.02 per share, while adjusted diluted EPS reached $2.16, slightly above the projected $2.13. For the full year, combined sales of Skyrizi and Rinvoq soared to $17.7 billion, marking a 51% surge driven by strong global demand and market expansion. Excluding Humira, total revenue grew 18% year-over-year, with the neuroscience and oncology segments leading the growth.